Back

A Diagnostic Blind Spot: Deep intronic SVA_E Insertion identified as the most Common Pathogenic Variant Associated with Canavan Disease

Dominguez Gonzalez, C. A.; Bell, K.; Rajagopalan, R.; de Silva, M. G.; Lemes, A.; Zabala, C.; Perez, F.; Cerisola, A.; Vossough, A.; Whitehead, M.; Cunningham, C.; Brown, N.; Quin, R.; Simons, C.; Uebergang, E.; Rius, R.; Kumaheri, M.; Kotes, E.; Vohra, A.; Sullivan, K. E.; Galey, M.; Anderson, Z.; Storz, S.; Ward, S.; Goffena, J.; Gustafson, J. A.; Conway, T.; White, S. M.; Vanderver, A.; Miller, D.

2024-12-21 genetic and genomic medicine
10.1101/2024.12.18.24318806 medRxiv
Show abstract

Canavan disease (CD) is a neurodegenerative disorder caused by biallelic disease-causing variants in the ASPA gene. Here, we utilized long-read sequencing (LRS) to investigate eight individuals clinically diagnosed with Canavan disease but without definitive genetic diagnoses. Our analyses identified a recurring previously unreported intronic SVA_E retrotransposon insertion within ASPA in all eight individuals. Surprisingly, the frequency of this variant in population databases suggests it is the most common pathogenic variant in ASPA and should be evaluated in diagnostic testing and carrier screening for CD. Additionally, this finding has implications for the broader rare disease community, as it highlights a substantial blind spot in standard short-read diagnostic pipelines, which historically have missed or overlooked these types of insertions. This discovery highlights the power of emerging technologies, such as LRS and RNA-sequencing (RNA-seq), to bring new classes of variants into diagnostic utility for genetic disorders like CD.

Matching journals

The top 5 journals account for 50% of the predicted probability mass.

50% of probability mass above

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.